Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass

Cell

Volumn 100, Issue 2, 2000, Pages 197-207

  Ducy, Patricia ^a   Amling, Michael ^b   Takeda, Shu ^a   Priemel, Matthias ^b   Schilling, Arndt F ^b   Beil, Frank T ^b   Shen, Jianhe ^a   Vinson, Charles ^c   Rueger, Johannes M ^b   Karsenty, Gerard ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HAMBURG   (Germany)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE ATROPHY; BONE MASS; CENTRAL NERVOUS SYSTEM FUNCTION; HYPERADRENOCORTICISM; HYPOGONADISM; MOUSE; NONHUMAN; OBESITY; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL;

ANIMALIA;

EID: 0141737573     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81558-5     Document Type: Article

References (50)

1. Ahima, R.S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., and Flier, J.S. (1996). Role of leptin in the neuroendocrine response to fasting. Nature 382, 250-252.
2. Ahima, R.S., Dushay, J., Flier, S.N., Prabakaran, D., and Flier, J.S. (1997). Leptin accelerates the onset of puberty in normal female mice. J. Clin. Invest. 99, 391-39 5.
3. Ahima, R.S., Bjorbek, C., Osei, S., and Flier, J.S. (1999). Regulation of neuronal and glial proteins by leptin: Implications for brain development. Endocrinology 140, 2755-2762.
4. Amling, M., Priemel, M., Holzmann, T., Chapin, K., Rueger, J.M., Baron, R., and Demay, M.B. (1999). Rescue of the skeletal phenotype of vitamin D receptor ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 140, 4982-4987.
5. Aschner, B. (1912). Uber die funktion der hypophyse. Pflügers Arch. Physiol. 146, 1-146.
6. Baumann, H., Morella, K.K., White, D.W., Dembski, M., Bailon, P.S., Kim, H., Lai, C.F., and Tartaglia, L.A. (1996). The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA 93, 8374-8378.
7. Bjorbaek, C., Elmquist, J.K., Frantz, J.D., Shoelson, S.E., and Flier, J.S. (1998). Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 4, 619-62 5.
8. Caro, J.F., Kolaczynski, J.W., Nyce, M.R., Ohannesian, J.P., Opentanova, I., Goldman, W.H., Lynn, R.B., Zhang, P.L., Sinha, M.K., and Considine, R.V. (1996). Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 348, 159-161.
9. Chehab, F., Lim, M., and Lu, R. (1996). Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet. 12, 318-320.
10. Chen, H., Charlat, O., Tartaglia, L.A., Woolf, E.A., Weng, X., Ellis, S.J., Lakey, N.D., Culpepper, J., Moore, K.J., Breitbart, R.E., et al. (1996). Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84, 491-49 5.
11. Chua, S.C.J., Koutras, I.K., Han, L., Liu, S.M., Kay, J., Young, S.J., Chung, W.K., and Leibel, R.L. (1997). Fine structure of the murine leptin receptor gene: Splice site suppression is required to form two alternatively spliced transcripts. Genomics 45, 264-270.
12. Consensus Development Conference: Prophylaxis and treatment of osteoporosis (1993). Am. J. Med., pp. 646-650.
13. Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., Ohannesian, J.P., Marco, C.C., McKee, L.J., and Bauer, T.L. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292-295.
14. Cooper, C., and Melton, L.J., III (1996). Magnitude and Impact of Osteoporosis and Fractures. In Osteoporosis, R. Marcus, D. Feldman, and J. Kelsey, eds. (San Diego, CA: Academic Press), pp. 419-434.
15. Ducy, P., Starbuck, M., Priemel, M., Shen, J., Pinero, G., Geoffroy, V., Amling, M., and Karsenty, G. (1999). A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13, 1025-103 6.
16. Elmquist, J.K., Ahima, R.S., Maratos-Flier, E., Flier, J.S., and Saper, C.B. (1997). Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 138, 839-842.
17. Elmquist, J.K., Elias, C.F., and Saper, C.B. (1999). From lesions to leptin: Hypothalamic control of food intake and body weight. Neuron 22, 221-23 2.
18. Eyre, D.R., Dickson, I.R., and Van Ness, K. (1988). Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mautre hydroxypyridinium residues. Biochemistry 252, 494-500.
19. Erickson, J.C., Hollopeter, G., and Palmiter, R.D. (1996). Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274, 1704-1707.
20. Felson, D.T., Zhang, Y., Hannan, M.T., and Anderson, J.J. (1993). Effects of weight and body mass index on bone mineral density in men and women: The Framingham study. J. Bone Miner. Res. 8, 567-573.
21. Friedman, J.M., and Halaas, J.L. (1998). Leptin and the regulation of body weight in mammals. Nature 395, 763-770.
22. Frost, H.M. (1969). Tetracycline-based histological analysis of bone remodeling. Calcif. Tissue Res. 3, 211-23 7.
23. Ghilardi, N., Ziegler, S., Wiestner, A., Stoffel, R., Heim, M.H., and Skoda, R.C. (1996). Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA 93, 6231-6235.
24. Halaas, J.L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D.A., and Friedman, J.M. (1997). Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. USA 94, 8878-888 3.
25. Herberg, L., and Coleman, D.L. (1977). Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 26, 59-99.
26. Ingalls, A.M., Dickie, M.M., and Snell, G.D. (1950). J. Hered. 41, 317-31 8.
27. Inoue, S., and Bray, G.A. (1977). The effect of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity. Endocrinology 100,108-114.
28. Inui, A. (1999). Feeding and body-weight regulation by hypothalamic neuropeptides-mediation of the actions of leptin. Trends Neurosci. 22, 62-67.
29. Kaufman, J.-M., Taelman, P., Vermeulen, A., and Vandeweghe, M. (1992). Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J. Clin. Endocrinol. Metab. 74, 118-123.
30. Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998). Osteoprotegerin lignad is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
31. Lee, G.H., Proenca, R., Montez, J.M., Carroll, K.M., Darvishzadeh, J.G., Lee, J.I., and Friedman, J.M. (1996). Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632-635.
32. Levy, J.B., Schindler, C., Raz, R., Levy, D.E., Baron, R., and Horowitz, M.C. (1996). Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. Endocrinology 137, 1159-116 5.
33. Maffei, M., Halaas, J., Ravussin, E., Pratley, R.E., Lee, G.H., Zhang, Y., Fei, H., Kim, S., Lallone, R., and Ranganathan, S. (1995). Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155-1161.
34. Moitra, J., Mason, M.M., Olive, M., Krylov, D., Gavrilova, O., Marcus- Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., Reitman, M.L., and Vinson, C. (1998). Life without white fat: A transgenic mouse. Genes Dev. 12, 3168-3181.
35. Moller, D.E., and Flier, J.S. (1991). Insulin resistance-mechanisms, syndromes, and implications. N. Engl. J. Med. 325, 938-948.
36. Namae, M., Mori, Y., Yasuda, K., Kadowaki, T., Kanazawa, Y., and Komeda, K. (1998). New method for genotyping the mouse Lep(ob) mutation, using a polymerase chain reaction assay. Lab. Anim. Sci. 48, 103-104.
37. Parfitt, A.M., Drezner, M.K., Glorieux, F.H., Kanis, J.A., Malluche, H., Meunier, P.J., Ott, S.M., and Recker, R.R. (1987). Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610.
38. Quinn, J.M., Elliott, J., Gillespie, M.T., and Martin, T.J. (1998). A combination of osteoclast differentiation factor and macrophagecolony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139, 4424-4427.
39. Ravn, P., Cizza, G., Bjarnason, N.H., Thompson, D., Daley, M., Wasnich, R.D., McClung, M., Hosking, D., Yates, A.J., and Christiansen, C. (1999). Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J. Bone Miner. Res. 14, 1622-1627.
40. Reid, I.R. (1997). Preventing glucocorticoid-induced osteoporosis. N. Engl. J. Med. 337, 420-421.
41. Riggs, B., Khosla, S., and Melton, M.J. (1998). A unitary model for involutional osteoporosis: Estrogen deficiency causes both Type I and Type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J. Bone Miner. Res. 13, 763-773.
42. Riggs, B.L., and Melton, L.J.I. (1986). Medical progress: Involutional osteoporosis. N. Engl. J. Med. 314, 1676-1678.
43. Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., Lüthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., et al. (1997). Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89, 309-319.
44. Spiegelman, B.M., and Flier, J.S. (1996). Adipogenesis and obesity: Rounding out the big picture. Cell 87, 377-389.
45. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T., and Martin, T.J. (1999). Modulatinof osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 3, 345-357.
46. Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G.J., Campfield, L.A., Clark, F.T., and Deeds, J. (1995). Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263-1271.
47. Thomas, T., Gori, F., Khosla, S., Jensen, M.D., Burguera, B., and Riggs, B.L. (1999). Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140, 1630-1638.
48. Tremollieres, F.A., Rouilles, J.M., and Ribot, C. (1993). Vertebral post-menopausal bone loss is reduced in overweight women: A longitudinal study in 155 early postmenopausal women. J. Clin. Endocrinol. Metab. 77, 683-68 6.
49. Vaisse, C., Halaas, J.L., Horvath, C.M., Darnell, J.E.J., Stoffel, M., and Friedman, J.M. (1996). Leptin activation of stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14, 95-97.
50. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J.M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.